Sveu breeding colony
Ended Awarded Last action
- Contract number
- HHSN27200004
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,116,116
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2012138 Solicitation number
- Contract value 100% obligated
- $15,116,116.33 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$152,913 | |
| Funding Only Action | $17,651 | |
| Funding Only Action | $110,474 | |
| Funding Only Action | -$4,379 | |
| Other Administrative Action | -$20,714 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $38,807 | |
| Funding Only Action | -$142,891 | |
| Exercise an Option | $2,371,101 | |
| Exercise an Option | $2,268,617 | |
| Funding Only Action | -$101,589 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,265,914 | |
| Exercise an Option | $2,166,265 | |
| Exercise an Option | $2,163,717 | |
| Exercise an Option | $2,069,231 | |
| Other Administrative Action | $0 | |
| Original award | $2,066,824 |
Show all 18
About this award
This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for the "Simian Vaccine Evaluation Units" program. The contract has a ceiling value of $15,116,116.33 and a period of performance through September 9, 2023. This is a delivery order issued under a larger Simian Vaccine Evaluation Units 2013-2020 IDIQ (Indefinite Delivery/Indefinite Quantity) contract. ABL, a for-profit manufacturer of biologics, is providing a range of preclinical development and manufacturing services to support NIAID's vaccine and therapeutic research programs, particularly for infectious disease countermeasures. Services include biologics production, analytical testing, stability studies, and other product development activities, primarily involving non-human primate studies. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN27200004?
HHSN27200004 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2013.
How much is contract HHSN27200004 worth?
The government has obligated $15,116,116 on HHSN27200004.
Is contract HHSN27200004 an order under another contract?
Yes. HHSN27200004 is a delivery order under HHSN272201300002I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract HHSN27200004 competed?
The extent of competition for HHSN27200004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award